Specialised gut immune cells pinpointed that can limit progression of inflammatory bowel disease
Researchers have shown how the presence of Vg4 T cells can reduce the risk of inflammatory bowel disease (IBD) relapse, which could not only be a new therapeutic avenue for IBD but also explain its link with colon cancer.
Researchers at King’s, the Francis Crick Institute, and Guy’s & St Thomas NHS Foundation Trust have characterised a specialised type of immune cell, which plays a key role in protecting and repairing the cells in the healthy human gut.
Read the fulll story